Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction. Tan YJ, Linden S, Ong SC. PLoS One 2024;19:e0305257.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan YJ, Linden S, Ong SC. Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction. PLoS One 2024;19:e0305257.
PMID: 39178204